Financials

News Discussions Technicals Seasonals

QLINEA fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Q-linea AB operates as a holding company. The firm engages in the development of inventive systems for in vitro diagnostics for infectious diseases. Its products include ASTar, ASTrID and Data. The company was founded by Jonas Sven Peter Jarvius, Bernitz Mats Bo Johan Nilsson, Jan Grawe and Johan Stenberg in April 2008 and is headquartered in Uppsala, Sweden.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

QLINEA has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company